Literature DB >> 19110046

A clinically relevant in vitro model for evaluating the effects of aerosolized vesicants.

Claudia Karacsonyi1, Naga Shanmugam, Elliott Kagan.   

Abstract

The chemical warfare vesicant sulfur mustard (HD) is a known toxic agent to the human respiratory tract and the major airways are considered to be a primary target of HD-induced injury. However, there is no consensus regarding which model systems are most appropriate for studying the effects of aerosolized vesicants on human airway epithelium. In this study, we evaluated the consequences of exposure of differentiated human respiratory epithelial cells in air-liquid interface to mechlorethamine (HN2), an HD functional analog. HN2 challenge was administered via the apical (air) interface over a wide dose range (20-400 microM) to differentiated HBE1 cells. Cultures were observed over 1-48 h for evidence of HN2-induced morphologic abnormalities as well as for possible cellular cytotoxicity, apoptotic changes, and induction of cytokine secretion. HN2 at concentrations of > or =200 microM caused disruption and denudation of the airway epithelial architecture within 24h of exposure. Moreover, HN2-induced cytotoxic and apoptotic changes in HBE1 cells in a dose- and time-dependent fashion. HN2 challenge also induced secretion of chemokines and proinflammatory cytokines including TNF-alpha, IL-1 alpha, IL-1 beta, IL-6, IL-8, RANTES, MCP-1, IP-10, G-CSF, GM-CSF and IL-15. These observations parallel those described in the lungs of HD-exposed victims and underscore the utility and potential applicability of this model to future mechanistic studies of vesicant-induced pulmonary injury.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19110046     DOI: 10.1016/j.toxlet.2008.11.015

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  8 in total

1.  Acute cytotoxicity and increased vascular endothelial growth factor after in vitro nitrogen mustard vapor exposure.

Authors:  Matthew D McGraw; So-Young Kim; Carl W White; Livia A Veress
Journal:  Ann N Y Acad Sci       Date:  2020-05-14       Impact factor: 5.691

2.  Sulfur mustard vapor effects on differentiated human lung cells.

Authors:  Jeanclare Seagrave; Waylon M Weber; Gary R Grotendorst
Journal:  Inhal Toxicol       Date:  2010-09       Impact factor: 2.724

Review 3.  Sulfur mustard-induced pulmonary injury: therapeutic approaches to mitigating toxicity.

Authors:  Barry Weinberger; Jeffrey D Laskin; Vasanthi R Sunil; Patrick J Sinko; Diane E Heck; Debra L Laskin
Journal:  Pulm Pharmacol Ther       Date:  2010-09-17       Impact factor: 3.410

4.  Doxycycline hydrogels with reversible disulfide crosslinks for dermal wound healing of mustard injuries.

Authors:  SivaNaga S Anumolu; Anupa R Menjoge; Manjeet Deshmukh; Donald Gerecke; Stanley Stein; Jeffrey Laskin; Patrick J Sinko
Journal:  Biomaterials       Date:  2010-10-14       Impact factor: 12.479

Review 5.  Anti-TNFα therapy in inflammatory lung diseases.

Authors:  Rama Malaviya; Jeffrey D Laskin; Debra L Laskin
Journal:  Pharmacol Ther       Date:  2017-06-19       Impact factor: 12.310

6.  Doxycycline loaded poly(ethylene glycol) hydrogels for healing vesicant-induced ocular wounds.

Authors:  SivaNaga S Anumolu; Andrea S DeSantis; Anupa R Menjoge; Rita A Hahn; John A Beloni; Marion K Gordon; Patrick J Sinko
Journal:  Biomaterials       Date:  2009-10-22       Impact factor: 12.479

7.  Apoptosis and the airway epithelium.

Authors:  Steven R White
Journal:  J Allergy (Cairo)       Date:  2011-12-13

8.  The injury progression of T lymphocytes in a mouse model with subcutaneous injection of a high dose of sulfur mustard.

Authors:  Yi-Zhou Mei; Xiao-Rui Zhang; Ning Jiang; Jun-Ping Cheng; Feng Liu; Pan Zheng; Wen-Xia Zhou; Yong-Xiang Zhang
Journal:  Mil Med Res       Date:  2014-12-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.